Posts tagged “Biotech & Life Science”
CoLucid Pharma leaves RTP; Cree LEDs for rural areas; new Samsung, HTC phones; 'Voice'-like app; PayPal's fine
In today's Bulldog wrapup of technology and life science news: CoLucid Pharmaceuticals leaves the Triangle; Cree targets rural areas with new LEDs; new Samsung and HTC phones coming April 10; a new "American Idol"- or "Voice"-like app launches; and PayPal pays $7.7 fine.
Google Fiber expands; Jim Goodnight's venture play; non-GMO food label; new Instagram app; GSK's next HQ in Asia
In today's Bulldog wrapup of technology and life science news: Google Fiber is expanding; Jim Goodnight's new venture play is biotech; a proposed label for non-GMO foods; Instagram has a new app; and GSK is building a new Asian headquarters.
At an event put on by the North Carolina Biotechnology Center and supported by GlaxoSmithKline, more than 300 people who are losing their jobs at GSK through layoffs gathered to hear about possible options for future employment. "There is life beyond GSK," former GlaxoWellcome CEO Robert Ingram tells the crowd.
In the latest news of progress on the Alzheimer's front, RTP-based T3D Therapeutics on Tuesday disclosed that it had received a $1.8 million grant from the National Institutes of Health for its development of a potential Alzheimer's treatment.
Cisco phone hack vulnerability; Google Glass not dead; gluten-free wheat; Square's biz fee; Ikea stops online mag in Russia
In today's Bulldog wrapup of tech and biotech news: Cisco warns about a vulnerability in its Internet phones; Google's Eric Schmidt backs Glass; researchers to seek gluten-free wheat; Square's "Cash" app for businesses; and Ikea drops its online magazine in Russia over gay law concerns.
Biogen is going back to its roots, changing the company's name after being known as Biogen Idec since 2003. The change reflects the focus of the company now vs. when it merged with Idec in 2003.
WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.
The Bill & Melinda Gates Foundation took a major role in trying to find a vaccine to treat Ebola, even providing funding to Durham-based Chimerix. Now, Bill Gates is warning that the world must prepare for future epidemics. If we are smart, we will listen and learn from what's happened from an outbreak that has killed some 10,000 people.
Potatoes that won't bruise and apples that won't brown are a step closer to grocery store aisles. The Food and Drug Administration on Friday approved the genetically engineered foods, saying they are "as safe and nutritious as their conventional counterparts."
Biogen Idec reports that a possible treatment for Alzheimer's under development by the company for the "first time" demonstrates the capability of reducing disease-related plaque in the brain and in slowing mental impairment in patients.
AT&T's $40M error; GSK job cuts; Amazon 1-hour delivery; Salix $78M parachutes; GSK inhaler; China freedom group attacked
In today's Bulldog wrapup of technology and life science news: AT&T takes a $40M hit in a lawsuit; GSK is cutting 150 jobs in Pa.; Amazon expands 1-hour delivery service; Salix handing out $78M in golden parachutes; GSK wins OK for inhaler; and a China web freedom group is under attack.
A senior executive at troubled drug giant GlaxoSmithKline says "social responsibility" is a major reason for its attempts to develop a vaccine to treat Ebola. Resources were diverted from other projects to support the Ebola fight, he says.
Fresh from $20M round, Durham startup Scioderm launches Phase 3 trial of treatment for 'butterfly children'
Durham-based Scioderm is launching today a Phase 3 clinical trial of a drug it hopes will be the first treatment for EB, "the worst disease you've never heard of." The rare skin disorder is also known for creating "butterfly children" who are adorned with bandages in an attempt to fight the disease.
Most people who visit the North Carolina Arboretum in Asheville enjoy it as a vacation stop at a "plant zoo" where the beauty and variety of the state's mountain vegetation can be enjoyed in a magnificent Appalachian setting. But the Arboretum is also an increasingly important scientific and economic resource for North Carolina.
GlaxoSmithKline, Biogen, other major drugmakers, the British government and a top Alzheimer's research charity are pooling more than $100 million to create a global fund to accelerate efforts to find a treatment or even a cure for the mind-robbing disease within a decade.
Livestock producers in North Carolina and other mid-Atlantic states are sharing some high-tech tools to fix a big, expensive food disparity. A collaborative venture is challenging academic research and industry experts in North and South Carolina, Virginia and Maryland to put their heads together and find ways to produce at least 50 percent more animal feed grain from crops especially well-suited to conditions in the mid-Atlantic region.
Blackberry-IBM-Samsung secure tablet; Cablevision-HBO Now; GSK Ebola update; Facebook's buy; Lyft lawsuit
In today's wrapup of technology and life science news: BlackBerry joins with IBM and Samsung to develop a secure tablet; GSK's Ebola vaccine advances; Cablevision hooks up with HBO Now; Facebook's latest buy; and did Lyft cheat drivers?
- US agency: Keep threatened status for green sea turtles
- Japan opts for massive, costly sea wall to fend off tsunamis
- Launch delayed for soil monitoring station
- Biogen tops sustainable corporations list; Novozomes, Lenovo, Cisco, EMC crack top 100
- Sea level report shows increasing pace of change along coast